Transfusion-associated graft versus host disease: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
==[[Transfusion-associated graft versus host disease overview|Overview]]== | |||
== | ==[[Transfusion-associated graft versus host disease historical perspective|Historical Perspective]]== | ||
==[[Transfusion-associated graft versus host disease classification|Classification]]== | |||
== | ==[[Transfusion-associated graft versus host disease pathophysiology|Pathophysiology]]== | ||
==[[Transfusion-associated graft versus host disease causes|Causes]]== | |||
== | ==[[Transfusion-associated graft versus host disease differential diagnosis|Differentiating Transfusion-associated graft versus host disease from other Diseases]]== | ||
== | ==[[Transfusion-associated graft versus host disease epidemiology and demographics|Epidemiology and Demographics]]== | ||
== | ==[[Transfusion-associated graft versus host disease risk factors|Risk Factors]]== | ||
==[[Transfusion-associated graft versus host disease screening|Screening]]== | |||
==[[Transfusion-associated graft versus host disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
[[Transfusion-associated graft versus host disease history and symptoms|History and Symptoms]] | [[Transfusion-associated graft versus host disease physical examination|Physical Examination]] | [[Transfusion-associated graft versus host disease laboratory findings|Laboratory Findings]] | [[Transfusion-associated graft versus host disease molecular_genetic_studies|Molecular Genetic Studies]] | [[Transfusion-associated graft versus host disease genotyping|Genotyping]] | [[Transfusion-associated graft versus host disease pelvic x ray|Pelvic X Ray]] | [[Transfusion-associated graft versus host disease CT|CT]] | [[Transfusion-associated graft versus host disease ultrasound|Ultrasound]] | [[Transfusion-associated graft versus host disease other imaging findings|Other Imaging Findings]] | [[Transfusion-associated graft versus host disease other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Transfusion-associated graft versus host disease medical therapy|Medical Therapy]] | [[Transfusion-associated graft versus host disease primary prevention|Primary Prevention]] | [[Transfusion-associated graft versus host disease secondary prevention|Secondary Prevention]] | [[Transfusion-associated graft versus host disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Transfusion-associated graft versus host disease future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Transfusion-associated graft versus host disease case study one|Case #1]] | |||
{{transfusion medicine}} | {{transfusion medicine}} |
Revision as of 14:34, 21 September 2012
Template:DiseaseDisorder infobox For patient information, click here
Transfusion-associated graft versus host disease Microchapters |
Differentiating Transfusion-associated graft versus host disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transfusion-associated graft versus host disease On the Web |
American Roentgen Ray Society Images of Transfusion-associated graft versus host disease |
Transfusion-associated graft versus host disease in the news |
Directions to Hospitals Treating Transfusion-associated graft versus host disease |
Risk calculators and risk factors for Transfusion-associated graft versus host disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Transfusion-associated graft versus host disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Molecular Genetic Studies | Genotyping | Pelvic X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies